Evol Science

Evol Science is a precision medicine company focused on developing novel cancer therapeutics that target the Evolutionary Stress Response (ESR). The company's proprietary platform identifies specific molecular pathways that cancer cells utilize to survive under extreme environmental stress and therapeutic pressure. By developing small molecule inhibitors against these master regulators, Evol Science aims to prevent the emergence of drug resistance and treat advanced, refractory solid tumors. Founded by leading researchers from Yale University, the company leverages advanced proteomics and systems biology to expand its pipeline of first-in-class oncology drugs.